Clinical trial
Effects of Baclofen on Presynaptic Inhibition in Humans
NCT04471714 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Baclofen on Presynaptic Inhibition in Humans
- Lead sponsor
- University of Alberta
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- January 10, 2020
- Completion date
- March 17, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spasticity, muscle, spinal cord injuries